{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:43:21Z","timestamp":1793666601477,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is no consensus regarding the choice of injected drugs for pathological scars. Although the clinical efficacy of different drug treatments was shown in many randomized controlled trials, the efficacies of many drugs are inconsistent. Therefore, this study aimed to determine how different effective drugs are for treating pathological scars. It is anticipated that the study findings may serve as guidelines for plastic surgeons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Relevant literature was extracted from the following databases Cochrane Library, Embase, PubMed, Web of Science, CNKI, Weipu, and Wanfang until June 2022, such as randomized clinical trials (RCTs) evaluating different injected drugs for the treatment of pathological scars, including BTA, TAC, 5-Fu, VER, and BLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This network meta-analysis of 1539 patients from 23 articles revealed that the most effective treatment for a pathological scar was TAC + BTA. The effective rate of TAC + BTA combination therapy was significantly different from that of the BTA, TAC, 5-Fu, VER, and BLM monotherapies. TAC+5-FU was more effective than TAC, 5-FU, VER, or BLM alone, and BTA was more effective than both TAC and 5-Fu. The effectiveness of VER and BLM was the same, but both were better than TAC and 5-Fu. No big differences were found between any of the other local injection therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>According to this network meta-analysis, a combination of keloid and hypertrophic scar injection treatment is recommended, especially BTA+TAC. However, this network meta-analysis has some limitations and must be further verified by larger samples and higher quality RCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence III<\/jats:title>\n                    <jats:p>\n                      This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.springer.com\/00266\">www.springer.com\/00266<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00266-022-03163-4","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T16:33:10Z","timestamp":1671467590000},"page":"465-472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparing the Efficacy of Multiple Drugs Injection for the Treatment of Hypertrophic Scars and Keloid: A Network Meta-Analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Wenhao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-4633","authenticated-orcid":false,"given":"Aimei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"issue":"S1","key":"3163_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","volume":"43","author":"B Berman","year":"2017","unstructured":"Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43(S1):S3\u2013S18","journal-title":"Dermatol Surg"},{"issue":"1","key":"3163_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.prs.0000195073.73580.46","volume":"117","author":"A Al-Attar","year":"2006","unstructured":"Al-Attar A, Mess S, Thomassen JM et al (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117(1):286\u2013300","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"3163_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/ijd.15159","volume":"60","author":"SF Ekstein","year":"2021","unstructured":"Ekstein SF, Wyles SP, Moran SL et al (2021) Keloids: a review of therapeutic management. Int J Dermatol 60(6):661\u2013671","journal-title":"Int J Dermatol"},{"issue":"3","key":"3163_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/wrr.12432","volume":"24","author":"RS Chiang","year":"2016","unstructured":"Chiang RS, Borovikova AA, King K et al (2016) Current concepts related to hypertrophic scarring in burn injuries. Wound Repair Regen 24(3):466\u2013477","journal-title":"Wound Repair Regen"},{"key":"3163_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s41038-015-0026-4","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Ding J, Tredget EE (2016) The molecular basis of hypertrophic scars. Burns Trauma. https:\/\/doi.org\/10.1186\/s41038-015-0026-4","journal-title":"Burns Trauma"},{"issue":"4","key":"3163_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/MOO.0000000000000268","volume":"24","author":"D Del Toro","year":"2016","unstructured":"Del Toro D, Dedhia R, Tollefson TT (2016) Advances in scar management: prevention and management of hypertrophic scars and keloids. Curr Opin Otolaryngol Head Neck Surg 24(4):322\u2013329","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"3163_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s13555-020-00427-2","volume":"10","author":"EE Limmer","year":"2020","unstructured":"Limmer EE, Glass DA 2nd (2020) A review of current keloid management: mainstay monotherapies and emerging approaches. Dermatol Ther (Heidelb) 10(5):931\u2013948","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"3163_CR8","first-page":"467","volume":"14","author":"J Poetschke","year":"2016","unstructured":"Poetschke J, Gauglitz GG (2016) Current options for the treatment of pathological scarring. J Dtsch Dermatol Ges 14(5):467\u2013477","journal-title":"J Dtsch Dermatol Ges"},{"issue":"7","key":"3163_CR9","first-page":"907","volume":"32","author":"A Asilian","year":"2006","unstructured":"Asilian A, Darougheh A, Shariati F (2006) New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 32(7):907\u2013915","journal-title":"Dermatol Surg"},{"issue":"2","key":"3163_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2230.2007.02631.x","volume":"34","author":"A Darougheh","year":"2009","unstructured":"Darougheh A, Asilian A, Shariati F (2009) Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 34(2):219\u2013223","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"3163_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12262-011-0399-y","volume":"74","author":"AK Saha","year":"2012","unstructured":"Saha AK, Mukhopadhyay M (2012) A comparative clinical study on role of 5-flurouracil versus triamcinolone in the treatment of keloids. Indian J Surg 74(4):326\u2013329","journal-title":"Indian J Surg"},{"issue":"9","key":"3163_CR12","first-page":"1003","volume":"64","author":"MA Khan","year":"2014","unstructured":"Khan MA, Bashir MM, Khan FA (2014) Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc 64(9):1003\u20131007","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"3163_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/jocd.12132","volume":"14","author":"K Payapvipapong","year":"2015","unstructured":"Payapvipapong K, Niumpradit N, Piriyanand C et al (2015) The treatment of keloids and hypertrophic scars with intralesional bleomycin in skin of color. J Cosmet Dermatol 14(1):83\u201390","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"3163_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bjps.2018.05.052","volume":"72","author":"KE Hietanen","year":"2019","unstructured":"Hietanen KE, J\u00e4rvinen TA, Huhtala H et al (2019) Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections - a randomized controlled trial. J Plast Reconstr Aesthet Surg 72(1):4\u201311","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"3163_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.burns.2018.08.011","volume":"45","author":"FA Khalid","year":"2019","unstructured":"Khalid FA, Mehrose MY, Saleem M et al (2019) Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: randomised control trial. Burns 45(1):69\u201375","journal-title":"Burns"},{"issue":"5","key":"3163_CR16","doi-asserted-by":"publisher","first-page":"e13036","DOI":"10.1111\/dth.13036","volume":"32","author":"HA Khan","year":"2019","unstructured":"Khan HA, Sahibzada MN, Paracha MM (2019) Comparison of the efficacy of intralesional bleomycin versus intralesional triamcinolone acetonide in the treatment of keloids. Dermatol Ther 32(5):e13036","journal-title":"Dermatol Ther"},{"issue":"7","key":"3163_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00403-020-02132-8","volume":"313","author":"SA Ismail","year":"2021","unstructured":"Ismail SA, Mohammed NHK, Sotohy M et al (2021) Botulinum toxin type A versus 5-fluorouracil in treatment of keloid. Arch Dermatol Res 313(7):549\u2013556","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"3163_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1524-4725.2011.02137.x","volume":"38","author":"A Sadeghinia","year":"2012","unstructured":"Sadeghinia A, Sadeghinia S (2012) Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids. Dermatol Surg 38(1):104\u2013109","journal-title":"Dermatol Surg"},{"issue":"10","key":"3163_CR19","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/ijd.14069","volume":"57","author":"A Aggarwal","year":"2018","unstructured":"Aggarwal A, Ravikumar BC, Vinay KN et al (2018) A comparative study of various modalities in the treatment of keloids. Int J Dermatol 57(10):1192\u20131200","journal-title":"Int J Dermatol"},{"issue":"4","key":"3163_CR20","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1080\/09546634.2021.1914307","volume":"33","author":"W Albalat","year":"2022","unstructured":"Albalat W, Nabil S, Khattab F (2022) Assessment of various intralesional injections in keloid: comparative analysis. J Dermatolog Treat 33(4):2051\u20132056","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"3163_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/09546634.2019.1628171","volume":"31","author":"HD Gamil","year":"2020","unstructured":"Gamil HD, Khattab FM, El Fawal MM et al (2020) Comparison of intralesional triamcinolone acetonide, botulinum toxin type A, and their combination for the treatment of keloid lesions. J Dermatolog Treat 31(5):535\u2013544","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"3163_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/jocd.12134","volume":"14","author":"E Shaarawy","year":"2015","unstructured":"Shaarawy E, Hegazy RA, Abdel Hay RM (2015) Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. J Cosmet Dermatol 14(2):161\u2013166","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"3163_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4103\/0378-6323.42899","volume":"74","author":"FX Margaret Shanthi","year":"2008","unstructured":"Margaret Shanthi FX, Ernest K, Dhanraj P (2008) Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol 74(4):343\u2013348","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"3163_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.burns.2013.09.029","volume":"40","author":"RB Ahuja","year":"2014","unstructured":"Ahuja RB, Chatterjee P (2014) Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Burns 40(4):583\u2013588","journal-title":"Burns"},{"issue":"2","key":"3163_CR25","first-page":"212","volume":"7","author":"S Srivastava","year":"2018","unstructured":"Srivastava S, Patil A, Prakash C et al (2018) Comparison of Intralesional Triamcinolone Acetonide, 5-fluorouracil, and their combination in treatment of Keloids. World J Plast Surg 7(2):212\u2013219","journal-title":"World J Plast Surg"},{"issue":"6","key":"3163_CR26","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.3892\/etm.2017.4438","volume":"13","author":"XE Chen","year":"2017","unstructured":"Chen XE, Liu J, Bin Jameel AA et al (2017) Combined effects of long-pulsed neodymium-yttrium-aluminum-garnet laser, diprospan and 5-fluorouracil in the treatment of keloid scars. Exp Ther Med 13(6):3607\u20133612","journal-title":"Exp Ther Med"},{"issue":"1","key":"3163_CR27","first-page":"25","volume":"16","author":"L Bin","year":"2017","unstructured":"Bin L, Jing L, Huiqing H (2017) Efficacy and safety of botulinum toxin type A on scar treatment. Chin J Dermatovenereol Integr Tradit West Med 16(1):25\u201327","journal-title":"Chin J Dermatovenereol Integr Tradit West Med"},{"issue":"23","key":"3163_CR28","first-page":"4434","volume":"18","author":"W Jw","year":"2018","unstructured":"Jw W, Jy Y, Jing L et al (2018) Research of efficacy and safety of botulinum toxin type A combined with compound betamethasone injection in treatment of patients with Keloid. Prog Mod Biomed 18(23):4434\u20134438","journal-title":"Prog Mod Biomed"},{"issue":"03","key":"3163_CR29","first-page":"158","volume":"32","author":"G Hui","year":"2021","unstructured":"Hui G, Yang W, Zhongbo L et al (2021) Clinical efficacy of botulinum toxin type A combined with compound betamethasone in the treatment of large area of hypertrophic scar. Chin J Aesthet Plast Surg 32(03):158\u2013162","journal-title":"Chin J Aesthet Plast Surg"},{"issue":"1","key":"3163_CR30","first-page":"33","volume":"12","author":"Z Ling","year":"2022","unstructured":"Ling Z, Yanping Z, Chao W (2022) A prospective randomized controlled study of botulinum toxin type A combined with compound betamethasone in the treatment of hypertrophic scar patientsbetamethasone in the treatment of hypertrophic scar patients. Chin Med Cosmetol 12(1):33\u201336","journal-title":"Chin Med Cosmetol"},{"issue":"3","key":"3163_CR31","first-page":"285","volume":"2","author":"S Sudulagunta","year":"2015","unstructured":"Sudulagunta S, Kumar B, Khorram H et al (2015) Comparison of combined intralesional Triamcinolone and 5-fluorouracil versus Bleomycin in Keloids. Int J Adv Health Sci (IJHS) 2(3):285\u2013289","journal-title":"Int J Adv Health Sci (IJHS)"},{"issue":"12","key":"3163_CR32","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/dsu.12346","volume":"39","author":"JA Ledon","year":"2013","unstructured":"Ledon JA, Savas J, Franca K et al (2013) Intralesional treatment for keloids and hypertrophic scars: a review. Dermatol Surg 39(12):1745\u20131757","journal-title":"Dermatol Surg"},{"issue":"5","key":"3163_CR33","first-page":"437","volume":"37","author":"N Lin","year":"2021","unstructured":"Lin N, Li M, Guo ZH et al (2021) A multicenter prospective randomized controlled clinical study of 5-fluorouracil in different mass concentrations combined with triamcinolone in the treatment of keloids. Zhonghua Shao Shang Za Zhi 37(5):437\u2013445","journal-title":"Zhonghua Shao Shang Za Zhi"},{"issue":"6","key":"3163_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/toxins14060406","volume":"14","author":"W Winayanuwattikun","year":"2022","unstructured":"Winayanuwattikun W, Vachiramon V (2022) Botulinum toxin type A for the treatment of skin ulcers: a review article. Toxins (Basel) 14(6):406","journal-title":"Toxins (Basel)"},{"issue":"1","key":"3163_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/01.prs.0000245337.38327.80","volume":"119","author":"MR Venus","year":"2007","unstructured":"Venus MR (2007) Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg 119(1):423\u2013424","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"3163_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/jocd.12534","volume":"17","author":"R Hao","year":"2018","unstructured":"Hao R, Li Z, Chen X et al (2018) Efficacy and possible mechanisms of botulinum toxin type A on hypertrophic scarring. J Cosmet Dermatol 17(3):340\u2013346","journal-title":"J Cosmet Dermatol"},{"issue":"suppl_1","key":"3163_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/asj\/sjx005","volume":"37","author":"J Schlessinger","year":"2017","unstructured":"Schlessinger J, Gilbert E, Cohen JL et al (2017) New uses of abobotulinumtoxinA in aesthetics. Aesthet Surg J 37(suppl_1):45\u201358","journal-title":"Aesthet Surg J"},{"issue":"2","key":"3163_CR38","first-page":"661","volume":"44","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lan D, Ning S et al (2019) Botulinum toxin type A prevents the phenotypic transformation of fibroblasts induced by TGF-\u03b21 via the PTEN\/PI3K\/Akt signaling pathway. Int J Mol Med 44(2):661\u2013671","journal-title":"Int J Mol Med"},{"issue":"8","key":"3163_CR39","first-page":"825","volume":"40","author":"MH Gold","year":"2014","unstructured":"Gold MH, McGuire M, Mustoe TA et al (2014) Updated international clinical recommendations on scar management: part 2\u2013algorithms for scar prevention and treatment. Dermatol Surg 40(8):825\u2013831","journal-title":"Dermatol Surg"},{"issue":"7","key":"3163_CR40","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.burns.2014.02.011","volume":"40","author":"AI Arno","year":"2014","unstructured":"Arno AI, Gauglitz GG, Barret JP et al (2014) Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns 40(7):1255\u20131266","journal-title":"Burns"},{"issue":"2","key":"3163_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jamafacial.2014.1355","volume":"17","author":"W Carroll","year":"2015","unstructured":"Carroll W, Patel K (2015) Steroids and fluorouracil for keloids and hypertrophic scars. JAMA Facial Plast Surg 17(2):77\u201379","journal-title":"JAMA Facial Plast Surg"},{"issue":"6","key":"3163_CR42","doi-asserted-by":"publisher","first-page":"Np567","DOI":"10.1093\/asj\/sjaa357","volume":"41","author":"P Wang","year":"2021","unstructured":"Wang P, Gu L, Bi H et al (2021) Comparing the efficacy and safety of intralesional verapamil with intralesional triamcinolone acetonide in treatment of hypertrophic scars and keloids: a meta-analysis of randomized controlled trials. Aesthet Surg J 41(6):Np567\u2013Np575","journal-title":"Aesthet Surg J"},{"issue":"2","key":"3163_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s13555-016-0118-5","volume":"6","author":"VV Shah","year":"2016","unstructured":"Shah VV, Aldahan AS, Mlacker S et al (2016) 5-Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature. Dermatol Ther (Heidelb) 6(2):169\u2013183","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"3163_CR44","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/SAP.0b013e3181978753","volume":"63","author":"XQ Wang","year":"2009","unstructured":"Wang XQ, Liu YK, Qing C et al (2009) A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann Plast Surg 63(6):688\u2013692","journal-title":"Ann Plast Surg"},{"issue":"1","key":"3163_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/jocd.13476","volume":"20","author":"DAE Abou-Taleb","year":"2021","unstructured":"Abou-Taleb DAE, Badary DM (2021) Intralesional verapamil in the treatment of keloids: a clinical, histopathological, and immunohistochemical study. J Cosmet Dermatol 20(1):267\u2013273","journal-title":"J Cosmet Dermatol"},{"issue":"1\u20132","key":"3163_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/14764172.2021.1950765","volume":"23","author":"J Kuang","year":"2021","unstructured":"Kuang J, An P, Li W (2021) Comparative efficacy and safety of verapamil and triamcinolone in keloid and hypertrophic scar treatment: a meta-analysis. J Cosmet Laser Ther 23(1\u20132):26\u201334","journal-title":"J Cosmet Laser Ther"},{"issue":"4","key":"3163_CR47","doi-asserted-by":"publisher","first-page":"e13564","DOI":"10.1111\/dth.13564","volume":"33","author":"R Liu","year":"2020","unstructured":"Liu R, Yang B, Deng Z et al (2020) Efficacy and safety of verapamil vs triamcinolone acetonide for keloids and hypertrophic scars: a systematic review and meta-analysis. Dermatol Ther 33(4):e13564","journal-title":"Dermatol Ther"},{"issue":"3","key":"3163_CR48","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/bjc.1993.100","volume":"67","author":"T Hendricks","year":"1993","unstructured":"Hendricks T, Martens MF, Huyben CM et al (1993) Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents. implications for wound healing. Br J Cancer 67(3):545\u2013550","journal-title":"Br J Cancer"},{"issue":"5","key":"3163_CR49","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00266-020-01721-2","volume":"44","author":"ZY Jiang","year":"2020","unstructured":"Jiang ZY, Liao XC, Liu MZ et al (2020) Efficacy and safety of intralesional triamcinolone versus combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: a systematic review and meta-analysis. Aesthetic Plast Surg 44(5):1859\u20131868","journal-title":"Aesthetic Plast Surg"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-022-03163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-022-03163-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-022-03163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T17:12:28Z","timestamp":1676999548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-022-03163-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3163"],"URL":"https:\/\/doi.org\/10.1007\/s00266-022-03163-4","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or Animal Rights"}},{"value":"For this type of study informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}